Lpl Financial LLC Seres Therapeutics, Inc. Transaction History

Lpl Financial LLC

  • $196 Billion
  • Q2 2024

A detailed history of Lpl Financial LLC transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 140,625 shares of MCRB stock, worth $115,312. This represents 0.0% of its overall portfolio holdings.

Number of Shares
140,625
Previous 129,775 8.36%
Holding current value
$115,312
Previous $99,000 2.02%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024
BUY
$0.56 - $1.19 $6,076 - $12,911
10,850 Added 8.36%
140,625 $101,000
Q1 2024

May 10, 2024
BUY
$0.75 - $1.56 $10,683 - $22,222
14,245 Added 12.33%
129,775 $99,000
Q4 2023

Feb 14, 2024
SELL
$0.93 - $2.15 $7,830 - $18,103
-8,420 Reduced 6.79%
115,530 $161,000
Q3 2023

Nov 13, 2023
BUY
$2.33 - $5.07 $20,718 - $45,082
8,892 Added 7.73%
123,950 $295,000
Q2 2023

Jul 31, 2023
BUY
$4.67 - $6.55 $90,541 - $126,991
19,388 Added 20.27%
115,058 $551,000
Q1 2023

May 10, 2023
BUY
$4.95 - $6.09 $13,706 - $16,863
2,769 Added 2.98%
95,670 $542,000
Q4 2022

Feb 07, 2023
SELL
$5.09 - $9.05 $41,748 - $74,228
-8,202 Reduced 8.11%
92,901 $520,000
Q3 2022

Nov 14, 2022
SELL
$3.5 - $7.2 $7,350 - $15,120
-2,100 Reduced 2.03%
101,103 $649,000
Q2 2022

Aug 12, 2022
BUY
$2.7 - $7.62 $143,353 - $404,576
53,094 Added 105.96%
103,203 $354,000
Q1 2022

May 16, 2022
BUY
$6.3 - $8.84 $26,510 - $37,198
4,208 Added 9.17%
50,109 $357,000
Q4 2021

Feb 14, 2022
BUY
$6.02 - $11.43 $23,345 - $44,325
3,878 Added 9.23%
45,901 $382,000
Q3 2021

Nov 15, 2021
SELL
$5.46 - $22.6 $123,827 - $512,545
-22,679 Reduced 35.05%
42,023 $292,000
Q2 2021

Aug 13, 2021
SELL
$18.46 - $24.36 $3,045 - $4,019
-165 Reduced 0.25%
64,702 $1.54 Million
Q1 2021

May 14, 2021
BUY
$17.66 - $28.92 $121,995 - $199,779
6,908 Added 11.92%
64,867 $1.34 Million
Q4 2020

Feb 12, 2021
SELL
$23.25 - $37.73 $26,458 - $42,936
-1,138 Reduced 1.93%
57,959 $1.42 Million
Q3 2020

Nov 09, 2020
SELL
$3.74 - $28.74 $57,648 - $442,998
-15,414 Reduced 20.69%
59,097 $1.67 Million
Q2 2020

Aug 13, 2020
SELL
$3.04 - $6.2 $5,523 - $11,265
-1,817 Reduced 2.38%
74,511 $355,000
Q1 2020

May 14, 2020
BUY
$2.64 - $3.82 $28,710 - $41,542
10,875 Added 16.61%
76,328 $272,000
Q4 2019

Feb 14, 2020
BUY
$2.99 - $4.42 $8,081 - $11,947
2,703 Added 4.31%
65,453 $226,000
Q3 2019

Nov 13, 2019
BUY
$2.29 - $4.16 $22,098 - $40,144
9,650 Added 18.17%
62,750 $252,000
Q2 2019

Aug 09, 2019
BUY
$2.28 - $7.35 $90,629 - $292,162
39,750 Added 297.75%
53,100 $171,000
Q1 2019

May 08, 2019
BUY
$4.83 - $7.21 $64,480 - $96,253
13,350 New
13,350 $92,000

Others Institutions Holding MCRB

# of Institutions
93
Shares Held
46.7M
Call Options Held
119K
Put Options Held
466K
View Full List

About Seres Therapeutics, Inc.

MCRB Quotes by TradingView
  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $102M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email